Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 212 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Improving the local excision strategy for rectal cancer after chemoradiotherapy: Surgical and oncological results.
Meillat H, Weets V, Saadoun JE, Tyran M, Mitry E, Illy M, de Chaisemartin C, Lelong B
Eur J Surg Oncol, 50(11):108639, 30 Aug 2024
Cited by: 0 articles | PMID: 39241510
Add to export list
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial.
Pinson J, Henriques J, Beaussire L, Sarafan-Vasseur N, Sa Cunha A, Bachet JB, Vernerey D, Di Fiore F, Schwarz L, PANACHE01-PRODIGE48 group
Ann Surg, 280(5):734-744, 05 Aug 2024
Cited by: 0 articles | PMID: 39101207
Add to export list
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma.
Fraunhoffer N, Hammel P, Conroy T, Nicolle R, Bachet JB, Harlé A, Rebours V, Turpin A, Ben Abdelghani M, Mitry E, Biagi J, Chanez B, Bigonnet M, Lopez A, Evesque L, Lecomte T, Assenat E, Bouché O, Renouf DJ, [...] Dusetti N
Ann Oncol, 35(9):780-791, 19 Jun 2024
Cited by: 0 articles | PMID: 38906254
Add to export list
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T
Lancet Oncol, 25(7):853-864, 01 Jun 2024
Cited by: 1 article | PMID: 38834087
Add to export list
Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
Gouton E, Gilabert M, Launay S, Loir E, Tyran M, Rochigneux P, Turrini O, Garnier J, Mitry E, Chanez B
Front Oncol, 13:1326676, 08 Jan 2024
Cited by: 0 articles | PMID: 38260832 | PMCID: PMC10800932
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Nicolle R, Bachet JB, Harlé A, Iovanna J, Hammel P, Rebours V, Turpin A, Ben Abdelghani M, Wei A, Mitry E, Lopez A, Biagi J, François E, Artru P, Lambert A, Renouf DJ, Monard L, Mauduit M, Dusetti N, [...] Cros J
J Clin Oncol, 42(9):1067-1076, 14 Nov 2023
Cited by: 4 articles | PMID: 37963313 | PMCID: PMC10950182
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Organ sparing to cure stage IV rectal cancer: A case report and review of literature.
Meillat H, Garnier J, Palen A, Ewald J, de Chaisemartin C, Tyran M, Mitry E, Lelong B
World J Gastrointest Surg, 15(11):2619-2626, 01 Nov 2023
Cited by: 0 articles | PMID: 38111764 | PMCID: PMC10725537
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.
Marx M, Caillol F, Godat S, Poizat F, Oumrani S, Ratone JP, Hoibian S, Dahel Y, Oziel-Taieb S, Niccoli P, Ewald J, Mitry E, Giovannini M
Ann Gastroenterol, 36(6):686-693, 30 Oct 2023
Cited by: 0 articles | PMID: 38023974 | PMCID: PMC10662066
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Peak Risk of Recurrence Occurs during the First Two Years after a Pancreatectomy in Patients Receiving Neoadjuvant FOLFIRINOX.
Alfano MS, Garnier J, Palen A, Ewald J, Piana G, Poizat F, Mitry E, Delpero JR, Turrini O
Cancers (Basel), 15(21):5151, 26 Oct 2023
Cited by: 1 article | PMID: 37958326 | PMCID: PMC10649429
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Boige V, Blons H, François E, Ben Abdelghani M, Phelip JM, Le Brun-Ly V, Mineur L, Galais MP, Villing AL, Hautefeuille V, Miglianico L, De La Fouchardière C, Genet D, Levasseur N, Levaché CB, Penel N, Mitry E, Jacquot S, Aparicio T, [...] Bouché O
JAMA Netw Open, 6(9):e2333533, 05 Sep 2023
Cited by: 3 articles | PMID: 37721754 | PMCID: PMC10507485
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments.
Varela Cagetti L, Moureau-Zabotto L, Zemmour C, Ferré M, Giovaninni M, Poizat F, Lelong B, De Chaisemartin C, Mitry E, Tyran M, Zioueche-Mottet A, Salem N, Tallet A
Brachytherapy, 22(4):531-541, 06 May 2023
Cited by: 3 articles | PMID: 37150739
Add to export list
Assessment of biological effect of nab-paclitaxel combined with gemcitabine, using contrast enhanced ultrasonography and elastography, in advanced pancreatic ductal carcinoma: A single-center pilot study.
Dahel Y, Chanez B, Zemmour C, Piana G, Mitry E, Giovannini M
Endosc Ultrasound, 12(2):273-276, 01 Mar 2023
Cited by: 1 article | PMID: 37148140 | PMCID: PMC10237618
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma.
Fraunhoffer N, Chanez B, Teyssedou C, Pdac Chemo Sensitivity Prediction Working Group, Iovanna JL, Mitry E, Dusetti NJ
Gastroenterology, 164(3):476-480.e4, 07 Dec 2022
Cited by: 6 articles | PMID: 36496056
Add to export list
Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study.
Rochigneux P, Tyran M, Autret A, Lopez Almeida L, Guiramand J, Ferre M, Chanez B, Mitry E, Ratone JP, Giovannini M, Tallet A, Moureau-Zabotto L, Caillol F
Front Oncol, 12:1012712, 28 Oct 2022
Cited by: 1 article | PMID: 36387207 | PMCID: PMC9650130
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P, Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group
JAMA Oncol, 8(11):1571-1578, 01 Nov 2022
Cited by: 80 articles | PMID: 36048453 | PMCID: PMC9437831
Add to export list Free full text in Europe PMC
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
Randrian V, Pernot S, Le Malicot K, Catena V, Baumgaertner I, Tacher V, Forestier J, Hautefeuille V, Tabouret-Viaud C, Gagnaire A, Mitry E, Guiu B, Aparicio T, Smith D, Dhomps A, Tasu JP, Perdrisot R, Edeline J, Capron C, [...] Tougeron D
Dig Liver Dis, 54(7):857-863, 21 May 2022
Cited by: 3 articles | PMID: 35610167
Add to export list
Avdoralimab (anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FORCE)
Carvelli J, Meziani F, Dellamonica J, Cordier P, Allardet-Servent J, Fraisse M, Velly L, Barbar S, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Zerbib R, Mitry E, Karakunnel J, Fares J, Batista L, [...] Group TFS
SSRN, 07 Feb 2022
Cited by: 0 articles | PPR: PPR603280
Add to export list Preprint Free full text in Europe PMC
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer.
Nicolle R, Gayet O, Bigonnet M, Roques J, Chanez B, Puleo F, Augustin J, Emile JF, Svrcek M, Arsenijevic T, Hammel P, Rebours V, Giovannini M, Grandval P, Dahan L, Moutardier V, Mitry E, Van Laethem JL, Bachet JB, [...] Dusetti NJ
Transl Oncol, 16:101315, 11 Dec 2021
Cited by: 8 articles | PMID: 34906890 | PMCID: PMC8681024
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
Vachenc S, Gobbo J, Moujarrebe SE, Desmoulins I, Gilabert M, Beau-Faller M, Mitry E, Girard N, Bertaut A, Dusetti N, Iovanna JL, Yousfi R, Pierrat F, Bruno R, Cueff A, Boidot R, Genne P
BMC Cancer, 22(1):41, 06 Jan 2022
Cited by: 0 articles | PMID: 34991520 | PMCID: PMC8734369
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials.
Rochigneux P, Chanez B, De Rauglaudre B, Mitry E, Chabannon C, Gilabert M
Cancers (Basel), 13(2):E271, 13 Jan 2021
Cited by: 30 articles | PMID: 33450845 | PMCID: PMC7828372
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.
Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Robak T, le Coutre PD, Gjertsen BT, Troussard X, Roboz GJ, Karlin L, Gladstone DE, Kuptsova-Clarkson N, Liu S, Patel P, Rotolo F, Mitry E, Pastan I, Giles F, Study 1053 investigators
J Hematol Oncol, 14(1):35, 24 Feb 2021
Cited by: 35 articles | PMID: 33627164 | PMCID: PMC7905554
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C, Explore COVID-19 IPH group, Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, [...] Vivier E
Nature, 588(7836):146-150, 29 Jul 2020
Cited by: 313 articles | PMID: 32726800 | PMCID: PMC7116884
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer.
Ou SI, Gadgeel SM, Barlesi F, Yang JC, De Petris L, Kim DW, Govindan R, Dingemans AM, Crino L, Léna H, Popat S, Ahn JS, Dansin E, Mitry E, Müller B, Bordogna W, Balas B, Morcos PN, Shaw AT
Lung Cancer, 139:22-27, 14 Oct 2019
Cited by: 13 articles | PMID: 31706099
Add to export list
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.
Pérol M, Pavlakis N, Levchenko E, Platania M, Oliveira J, Novello S, Chiari R, Moran T, Mitry E, Nüesch E, Liu T, Balas B, Konopa K, Peters S
Lung Cancer, 138:79-87, 11 Oct 2019
Cited by: 14 articles | PMID: 31654838
Add to export list
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Dohan A, Gallix B, Guiu B, Le Malicot K, Reinhold C, Soyer P, Bennouna J, Ghiringhelli F, Barbier E, Boige V, Taieb J, Bouché O, François E, Phelip JM, Borel C, Faroux R, Seitz JF, Jacquot S, Ben Abdelghani M, [...] PRODIGE 9 Investigators and PRODIGE 20 Investigators
Gut, 69(3):531-539, 17 May 2019
Cited by: 61 articles | PMID: 31101691
Add to export list

1-25 of 212 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding